Susan Hasty, Publisher
Table of Contents . . . August 30th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis C - Pegylated interferon and ribavirin cures many with hepatitis C virus infection
Immunology - Tests for anti-E2 antibody enhance hepatitis C detection in dialysis patients
Renal Transplant - Ultralow-dose interferon plus ribavirin helps HCV-positive kidney recipients
Transfusion Medicine - Blood donation may be a source of hepatitis E virus transmissions in Japan
Virology - NS5A protein confers a multiplicative advantage to hepatitis C virus
Business & Finance - LymphoStat-B maker reports losses, milestones in Q2 2004
Carcinogenesis - Fumonisin B-1 encourages liver disease and liver cancer formation
Chronic Liver Disease - Liver-directed cell therapy is expected to augment organ shortages
Complementary and Alternative Medicine - Herbal medicine-induced hepatotoxicity is becoming more prevalent
Diagnostics - Low viremia accounts for seronegative diagnoses in some hepatitis B carriers
Disease Associations - New data continues to link hepatitis C virus with non-Hodgkin's lymphoma
Drug Resistance - Hepatitis C virus core protein blocks interferon-induced STAT importation
Endocrinology - Estrogen suppression offers no protection to murine steatohepatitis models
Fatty Liver Disease - Weight reduction benefits children with non-alcoholic steatohepatitis
Finance - Alferon N maker announces private placement of common stock and warrants
Finance - Biopharmaceutical company reports second quarter results
Finance - Pharma company announces second quarter 2004 financial results
Genomics - PRDM5 gene is silenced in human cancers and has growth-suppressive activities
Hematology - Major beta-thalassemia complications are primarily age-related in North America
Hepatitis - Biotechnology company announces results of hepatitis C quality of life study
Hepatitis A Vaccine - Inactivated hepatitis A vaccine effective in children with liver disease
Hepatitis B - Liver transplantation outcomes have significantly improved
Hepatitis B Therapy - Multi-national phase II trial to study Remofovir in hepatitis B patients
Hepatitis B Vaccine - Hepatitis B vaccine plus lamivudine did not eliminate viral DNA
Hepatitis B Virus - Pharmaceuticals company initiates phase 2 clinical trials of hepatitis B drug
Hepatitis Epidemiology - Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers
Hepatitis Therapy - New drug combination appears promising for those with HIV and hepatitis C
Hepatocellular Carcinoma - Specificity of hepatocyte paraffin 1 determined
Immunology - Fetal stem cells transfer to and remain in maternal bone and bone marrow
Liver Fibrosis - Study demonstrates that FXR agonist can reverse liver fibrosis
Occupational Health - Hepatitis B virus test results dictate caution when worker tasks are at risk
Oncology - Disruptions of the p53-p21/WAF1 pathway alter liver cancer progression
Sexual and Reproductive Health - Survey reveals surprising insights into parental attitudes toward teen sex
Transfection - Herpes simplex virus type 1 can infect cells via non-HSV-specific receptors
Transfusion Medicine - Polytransfused children in France show high rates of GB virus C infection
Transplant Medicine - Graft-versus-host disease spawns acute hepatitis after stem cell transfer
Viral Epidemiology - At least three new HCV type 6 subgroups prevail among Myanmar blood donors
Viral Genomics and Genetics - Phylogenetic analysis defines the Tunisian epidemiology of hepatitis C virus
Viral Kinetics - Hepatitis D virus ribozyme-substrate complexes feature novel structures
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.